Stifel Financial Corp Alector, Inc. Transaction History

Stifel Financial Corp

$86.8 Billion
Q2 2024

A detailed history of Stifel Financial Corp transactions in Alector, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 214,011 shares of ALEC stock, worth $999,431. This represents 0.0% of its overall portfolio holdings.

Number of Shares

214,011

Previous 146,688 45.9%

Holding current value

$999,431

Previous $883,000 9.97%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.19 - $6.23 $282,083 - $419,422	67,323 Added 45.9%	214,011 $971,000
Q1 2024 May 13, 2024	BUY	$5.69 - $8.08 $5,286 - $7,506	929 Added 0.64%	146,688 $883,000
Q4 2023 Feb 12, 2024	BUY	$3.77 - $8.39 $450,925 - $1 Million	119,609 Added 457.4%	145,759 $1.16 Million
Q3 2023 Nov 13, 2023	BUY	$5.2 - $8.77 $1,040 - $1,754	200 Added 0.77%	26,150 $169,000
Q2 2023 Aug 14, 2023	BUY	$5.86 - $7.93 $1,072 - $1,451	183 Added 0.71%	25,950 $155,000
Q1 2023 May 12, 2023	BUY	$5.85 - $9.84 $2,340 - $3,936	400 Added 1.58%	25,767 $159,000
Q4 2022 Feb 13, 2023	BUY	$6.88 - $9.55 $21,328 - $29,605	3,100 Added 13.92%	25,367 $234,000
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $6,142 - $9,900	750 Added 3.49%	22,267 $211,000
Q2 2022 Aug 15, 2022	BUY	$7.65 - $14.24 $2,616 - $4,870	342 Added 1.62%	21,517 $219,000
Q1 2022 May 13, 2022	BUY	$13.02 - $20.78 $6,510 - $10,390	500 Added 2.42%	21,175 $302,000
Q4 2021 Feb 14, 2022	SELL	$19.35 - $25.54 $96 - $127	-5 Reduced 0.02%	20,675 $427,000
Q3 2021 Nov 15, 2021	SELL	$21.65 - $39.49 $21,650 - $39,490	-1,000 Reduced 4.61%	20,680 $472,000
Q2 2021 Aug 13, 2021	BUY	$15.5 - $22.48 $54,870 - $79,579	3,540 Added 19.51%	21,680 $451,000
Q1 2021 May 14, 2021	BUY	$14.84 - $22.23 $269,197 - $403,252	18,140 New	18,140 $365,000

Others Institutions Holding ALEC

# of Institutions

165

Shares Held

58.1M

Call Options Held

57K

Put Options Held

14.9K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $386M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Alector, Inc. Transaction History